Abstract

Since the introduction of shoulder arthroplasty in 1893 by the French surgeon Jule-Emile Pean [18], the indications for shoulder replacement have expanded. Today shoulder arthroplasty is a common treatment for glenohumeral osteoarthritis [2]. Shoulder arthroplasty can significantly improve the function of osteoarthritic shoulders [7, 13, 19, 27]. Comparing the results, TSR offers better shortand mid-term results, but has the risk of long-term problems as the glenoid loosening [2]. In our practice patients with glenohumeral osteoarthritis will receive a total shoulder arthroplasty. As an exception patients with osteoarthritis which is limited to the humeral head without eccentric erosion of a stable sclerotic glenoid (Typ A1 glenoid according to Walch [28]) can be treated with hemiarthroplasty (HA). If the glenoid shows eccentric posterior wear (> A1), a TSR is recommended. The use of total shoulder replacement in the setting of rotator cuff-tear arthropathy (CTA) has led to poor outcomes because of early glenoid implant failure [17]. These failures were the result of early glenoid loosening caused by altered biomechanics in the cuff-deficient shoulder. The treatment of choice for most used to be hemiarthroplasty. Although good relief from pain has usually been obtained, most patients with CTA and subsequent hemiarthroplasty had a limited range of movement, leading to difficulties with the activities of daily living. These poor results let to the development of the reverse shoulder prosthesis, as a new method for treating CTA. Using the reverse prosthesis in CTA, favorable outcomes have been reported [15, 17]. In order to use the replaced shoulder for ADLs the concerted function of the active stabilizers and the passive restraints of the replaced shoulder joint is necessary.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call